ArticleSouth African journal of sports medicine2026
Athletes' optimal brain care at risk: Should vestibular-ocular motor screening replace established neurocognitive protocols?
Article in South African journal of sports medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent recommendations in South Africa propose replacing validated neurocognitive baseline and post-injury assessment with NeuroFlex, a vestibular-ocular motor test, as part of a proposed new paradigm in concussion management. This commentary examines the clinical, regulatory, and ethical implications of excluding neurocognitive testing and removing neuropsychologist oversight from concussion protocols. Available evidence indicates that NeuroFlex does not currently hold FDA clearance and lacks validation for concussion identification. In contrast, established platforms such as ImPACT and Sway Medical possess FDA clearance and robust peer-reviewed support for concussion assessment. Neuropsychologists play a critical role in interpreting cognitive data, guiding academic and return-to-play decisions, and monitoring longitudinal cognitive health through annual baseline testing, functions not replaced by vestibular-ocular motor measures. Our evidence-based recommendations advocate routine inclusion of post-injury neurocognitive assessment with neuropsychologist application, preferably including baseline evaluation; optional research-based use of Neuroflex in conjunction with cognitive testing; and transparent, scientifically informed consent for all protocol changes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.